Anti-abuse label approved for painkiller Embeda

Published



The U.S. Food and Drug Administration says it has approved new labeling for another opioid designed to limit painkiller abuse.

The FDA said Friday that Pfizer Inc.’s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.